Fatty liver disease, also known as hepatic lipidosis, is a serious and potentially life-threatening metabolic condition in guinea pigs characterized by the abnormal accumulation of fat within the liver cells. This condition occurs when the body mobilizes fat stores for energy but the liver becomes overwhelmed and unable to process the incoming lipids efficiently. The excess fat infiltrates the liver tissue, impairing normal liver function and, if severe enough, leading to liver failure and death. Hepatic lipidosis is one of the most significant metabolic emergencies in guinea pigs and requires aggressive treatment to reverse the condition before permanent liver damage occurs.
Hepatic lipidosis most commonly develops in guinea pigs during periods of negative energy balance, when the animal is not consuming enough calories to meet its metabolic needs. This situation occurs most frequently in obese guinea pigs that stop eating, pregnant or nursing sows with high energy demands, and any guinea pig experiencing anorexia from illness, stress, or dental problems. Obesity is a major predisposing factor because these guinea pigs have large fat stores that can be rapidly mobilized, and their livers may already be under metabolic stress. The condition can develop surprisingly quickly, sometimes within just a few days of reduced food intake in susceptible individuals.
The impact of hepatic lipidosis on guinea pig health is severe and rapidly progressive. As fat accumulates in the liver, normal liver functions including metabolism of nutrients, production of proteins, and detoxification become impaired. Affected guinea pigs develop metabolic derangements including hypoglycemia and ketosis. The condition causes profound weakness, depression, and further loss of appetite, creating a vicious cycle where the anorexia that triggered the problem worsens as the guinea pig becomes sicker. Without treatment, hepatic lipidosis progresses to liver failure, coma, and death, often within days of the onset of clinical signs.
Despite its severity, hepatic lipidosis can be successfully treated if recognized and addressed early and aggressively. Treatment focuses on reversing the negative energy balance through nutritional support, addressing any underlying conditions that caused the initial anorexia, and supporting the liver through the recovery process. Syringe feeding is typically essential because affected guinea pigs will not eat voluntarily. Prevention is preferable to treatment and involves maintaining guinea pigs at healthy weights, ensuring consistent food intake, and promptly addressing any conditions that might cause reduced eating. Understanding the risk factors and early warning signs enables owners and veterinarians to intervene before the condition becomes advanced.
